Inactivated sorbate vaccine against bovine parainfluenza-3 and infectious bovine rhinotracheitis

Description

Vaccine is intended for bovine parainfluenza-3 (BPI-3) and infectious bovine rhinotracheitis (IBR) prevention on farms infected with and farms at risk of these diseases. The vaccine dosage form is a suspension for injections. The vaccine is a homogeneous suspension of pink colour. Loose sediment forms during its storage that is easily resuspended by shaking. Both monovalent and bivalent vaccines can be produced.

Indications

The vaccine is intended for bovine parainfluenza-3 (BPI-3) and infectious bovine rhinotracheitis (IBR) prevention on farms infected with and at risk of the said diseases.

Route of administration

The vaccine is administered intramuscularly in the middle third of the neck. The site of injection is treated with 70% ethanol or other disinfecting solution. The vaccine shall be shaken well to make it homogeneous before administration and regularly during the vaccination procedure. The volume of the vaccine dose is 3 cm3. Disposable or reusable syringes and needles as well as autoinjectors sterilized by boiling in water for 15-20 min should be used for the vaccination. Sterilization of syringes, needles and autoinjectors with chemicals is prohibited. On infected farms all cattle should be vaccinated twice with a 21-30 day interval. Revaccination shall be performed by single vaccine administration 6 months after. On farms at risk 20-30-day-old calves should be vaccinated twice with a 21-30-day interval. Revaccination should be carried out by single vaccine administration 6 months after the first vaccination and then annually. Heifers and cows should be vaccinated twice with a 21-30 day interval 1.5-2.0 months prior to calving; heifers ready for breeding should be vaccinated twice with a 21-30 day interval prior to the first service and revaccinated 6 months later.

Immunity

The vaccine induces the immune response in cattle to bovine parainfluenza-3 and infectious bovine rhinotracheitis viruses on day 14-21 after the second vaccination. The immunity lasts for at least 6 months. The vaccine is innocuous and has no therapeutic effect.

Storage conditions

The vaccine should be stored and transported in dry dark place at 2 – 8 °C. Freezing of the vaccine is not allowed. The vaccine shelf life is 12 months from the date of its production provided that its storage and transportation conditions are met.

Disease: 
bovine parainfluenza-3 (BPI-3), infectious bovine rhinotracheitis (IBR)
Strain/ serotype: 
VGNKI-4/ARRIAH
Appearance: 
inactivated sorbate
Filling/ dosage: 
45, 90 and 1 95 cm3 bottles
Measurement unit: 
one thousand doses
Instructions: 
Certificates: